|
January 16, 2006 Categories: Uncategorized Posted by admin
Guidant Corp.’s board on Friday accepted a sweetened, $24.2 billion buyout offer from Johnson & Johnson, rejecting a richer Boston Scientific Corp. bid for the troubled cardiac device maker.
J&J agreed to pay $40.52 in cash and 0.493 share of Johnson & Johnson stock, with a total value of $71 a share, the companies said. Boston Scientific raised its offer Thursday by $1 a share to $73, half in cash and half stock, totaling about $25 billion.
Full news
|
|
